Pharmala Biotech Holdings MDMA Operating Margins

Operating Margin in 2022: -1.43%

According to Pharmala Biotech Holdings latest financial reports the company has an operating margin of -1.43%, an decrease of -88.64% to 2022. At the end of 2022 company had an operating margin of -12.62%.

Pharmala Biotech Holdings Operating Margin from 2022 to 2024

MDMA Operating Margin History by year

View the highest operating margin companies